SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-234472
Filing Date
2012-05-15
Accepted
2012-05-15 16:01:47
Documents
9
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d330743d10q.htm 10-Q 194287
2 SECTION 302 CEO CERTIFICATION d330743dex311.htm EX-31.1 10146
3 SECTION 302 CFO CERTIFICATION d330743dex312.htm EX-31.2 10160
4 SECTION 906 CEO AND CFO CERTIFICATION d330743dex32.htm EX-32 5654
  Complete submission text file 0001193125-12-234472.txt   917255

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT corx-20120331.xml EX-101.INS 65679
6 XBRL TAXONOMY EXTENSION SCHEMA corx-20120331.xsd EX-101.SCH 6731
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE corx-20120331_cal.xml EX-101.CAL 24046
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE corx-20120331_lab.xml EX-101.LAB 74326
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE corx-20120331_pre.xml EX-101.PRE 50196
Mailing Address 15241 BARRANCA PARKWAY IRVINE CA 92718
Business Address 15241 BARRANCA PKWY IRVINE CA 92718 7147273157
CORTEX PHARMACEUTICALS INC/DE/ (Filer) CIK: 0000849636 (see all company filings)

IRS No.: 330303583 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-16467 | Film No.: 12844475
SIC: 2834 Pharmaceutical Preparations